Shockwave Medical: A Look Into Q1 Financials And Value To Johnson & Johnson Investors

Date:


Coronary arteries

7activestudio/iStock via Getty Images

Thesis

Considering Shockwave Medical’s (NASDAQ:SWAV) latest Q1 2024 report, which revealed positive trends in sales, revenue and cash flow, the increasing market value and adoption of the intravascular lithotripsy (IVL) technology, together with the positive results of the



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Tile Shop: Focus On Channel And Product Growth Strategies (NASDAQ:TTSH)

Elevator Pitch Tile Shop Holdings,...

Families of Uvalde shooting victims sue Activision and Meta

The families of victims of the shooting at...